Tokushima University / Educator and Researcher Directory --- Mori, Tatsuo

Field of Study

○	Pediatric Neurology

Subject of Study

○

Book / Paper

Book:

1.	Kenji Mori and Tatsuo Mori : てんかん, 株式会社中外医学社, Tokyo, Jan. 2021.
2.	Yoshihiro Touda, Aya Gohji, Tatsuo Mori, Shoji Kagami, 青天目信 and 下野九理子 : A case of glucose transporter 1 (GLUT1) deficiency treated with ketone diet for a long time., 特殊ミルク共同安全開発委員会, Tokyo, Nov. 2019. (Keyword) グルコーストランスポーター1欠損症 / GLUT1
3.	Tatsuo Mori and 高橋幸利 : 中心側頭部に棘波をもつ良性小児てんかん(BECT), 株式会社診断と治療社, Tokyo, Apr. 2019.

Academic Paper (Judged Full Paper):

1.	野崎夏江 (名), Kenji Mori, Tetsuya Tanioka, 森慶子, Kumi Takahashi, Hiroko Hashimoto, Takahiro Tayama, Aya Gohji and Tatsuo Mori : Bilateral Prefrontasl Cortex Blood Flow Dynamics during Silent and Oral Reading Using Near-Infrared Spectroscopy, The Journal of Medical Investigation : JMI, Vol.71, No.1,2, 92-101, 2024. (Keyword) near infrared spectroscopy / Silent and Oral Reading
2.	森慶子, Kenji Mori, 野崎夏江 (名), 岡本里恵 (名), Fumiko Murao, Kumi Takahashi, Hiroko Hashimoto, Takahiro Tayama, Aya Gohji and Tatsuo Mori : 個別学習を行った限局性学習症を有する子どもの脳機能評価, 小児保健とくしま, No.30, 28-33, 2023. (Keyword) 限局性学習症 / 脳機能評価 / NIRS
3.	Takahiro Tayama, Shunsuke Takeuchi, Mikiko Takei, Keisuke Fujioka, Akemi Ono, Miki Shono, 七條光市, Shuji Kondo, Shoko Fukura, Aya Gohji, Tatsuo Mori and Toshiyuki Takahashi : 亜急性髄膜炎で発症後に，脳脊髄炎を呈したMOG抗体関連疾患の1例, No to Hattatsu, Vol.55, No.5, 2023.
4.	Tatsuo Mori, Masamune Sakamoto, Takahiro Tayama, Aya Goji, Yoshihiro Toda, Atsushi Fujita, Takeshi Mizuguchi, Maki Urushihara and Naomichi Matsumoto : A case of epilepsy with myoclonic atonic seizures caused by SLC6A1 gene mutation due to balanced chromosomal translocation., Brain & Development, Vol.45, No.7, 395-400, 2023. (Summary) The SLC6A1 disruption by chromosome translocation well explains the clinical features of this patient. Long-read sequencing is a powerful technique to determine genomic abnormality at the nucleotide level for disease-associated chromosomal abnormality. (Keyword) Humans / Child / Female / Infant / Child, Preschool / Translocation, Genetic / Epilepsies, Myoclonic / Mutation / Seizures / Anticonvulsants / Valproic Acid / Electroencephalography / GABA Plasma Membrane Transport Proteins (Tokushima University Institutional Repository) ● Metadata: 118474 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2023.03.001 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36966012 ● Search Scopus @ Elsevier (PMID): 36966012 ● Search Scopus @ Elsevier (DOI): 10.1016/j.braindev.2023.03.001 (Tokushima University Institutional Repository: 118474, DOI: 10.1016/j.braindev.2023.03.001, PubMed: 36966012)
5.	Kouhei Kamoi, 大山正弘, Keiichiro Watanabe, Ryuji Nakagawa, Tatsuo Mori, Satoshi Koyama, Aya Gohji, Junya Fukuda and 富永賢 : ピエール・ロバン症候群乳児における維持と調整機構を付与したPre-epiglottic baton plateの製作, Journal of Japanese Academy of Oral and Maxillofacial Rehabilitation Technology, Vol.22, No.1, 9-15, 2022.
6.	Shunsuke Takeuchi, Tatsuo Mori, Aya Gohji, Toshiyuki Takahashi and Yoshihiro Touda : Effective plasmapheresis treatment of intractable visual symptoms of MOG antibody-related disorders, No to Hattatsu, Vol.54, No.6, 421-425, 2022. (Keyword) MOG抗体 / 視神経炎 / 血漿交換 / 急性散在性脳脊髄炎 / 維持療法 / myelin oligodendrocyte glycoprotein / optic neuritis / plasmapheresis / acute disseminated encephalomyelitis / maintenance steroids (Link to Publication Site) ● Publication site (DOI): 10.11251/ojjscn.54.421 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390294341169669632 ● Search Scopus @ Elsevier (DOI): 10.11251/ojjscn.54.421 (DOI: 10.11251/ojjscn.54.421, CiNii: 1390294341169669632)
7.	Shun Aoi, Hidehiro Umehara, Aya Gohji, Tatsuo Mori, Yoshihiro Touda, 高橋幸利 and Tetsuro Ohmori : 免疫療法が著効し，髄液中の抗グルタミン酸受容体抗体が陽性であった小児自己免疫性溶連菌感染関連性精神神経障害が疑われた1例, Psychiatria et Neurologia Japonica, Vol.124, No.7, 447-456, 2022. (Keyword) 小児自己免疫性溶連菌感染関連性精神神経障害 / チック症候群 / 強迫性障害 / 免疫療法 / pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) / tic disorder / obsessive-compulsive disorder (OCD) / immunotherapy / ショウニジコメンエキセイヨウレンキンカンセンカンレンセイセイシンシンケイショウガイ / チックショウコウグン / キョウハクセイショウガイ / メンエキリョウホウ (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520011638683069824 (CiNii: 1520011638683069824)
8.	Kenji Mori, 森慶子, 野崎夏江, 河井ちひろ, Kumi Takahashi, Hiroko Hashimoto, Aya Gohji and Tatsuo Mori : 読字障害と脳活動に関する最新の研究, 精神科, Vol.41, No.1, 126-132, 2022. (Keyword) dyslexia / near-infrared spectroscopy(NIRS) / brain activity / reading aloud / silent reading
9.	Tatsuo Mori, Goji Aya, Toda Yoshihiro, Hiromichi Ito, Toshitaka Kawarai, Fujita Atsushi, Matsumoto Naomichi and Kenji Mori : A partial ARID1B deletion in a female child with intractable epilepsy, Epilepsy & Seizure, Vol.13, No.1, 45-50, 2021. (Keyword) Epilepsy / Coffin-Siris syndrome / ARID1B, / partial gene deletion / sodium valproate (Tokushima University Institutional Repository) ● Metadata: 116186 (Link to Publication Site) ● Publication site (DOI): 10.3805/eands.13.45 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.3805/eands.13.45 (Tokushima University Institutional Repository: 116186, DOI: 10.3805/eands.13.45)
10.	Tatsuo Mori, Aya Gohji, Yoshihiro Touda, Asami Okada, Yumiko Kotani and Shoji Kagami : Usefulness of individual support and medication for autism spectrum disorder traits in a boy with cyclic vomiting syndrome, No to Hattatsu, Vol.53, No.1, 54-57, 2021. (Summary) Herein we report the case of a 7-year-old boy with cyclic vomiting syndrome (CVS) successfully treated with judicious management and medication of autism spectrum disorder (ASD) traits. Radical surgery for esophageal atresia (Gross C) was performed during the neonatal period. The patient's mother and grandmother both had migraines. The cyclic vomiting began when he was 1 year and 4 months of age, and the episodes occurred 1-3 times monthly. Various drug treatments were tested, but were not effective in controlling the vomiting events. The patient was referred to our hospital at the age of 7 years and 4 months for consultation and treatment. We arrived at a diagnosis of ASD due to observable traits including avoidance of eye contact, obsessiveness, and difficulty in communication. Subsequently, we began individual support and medication for ASD traits to alleviate the CVS. The school has begun to support for his behaviors associated with ASD. Consequently, the psychological anxiety regarding school attendance was addressed, allowing the patient to return to school. When prophylactic drug treatment was changed to the combination of risperidone, amitriptin, and sodium valproate, the vomiting attacks discontinued. The patient is now aged 9 years and 3 months, and has experienced no recurrent vomiting episodes in the past 14 months. In conclusion, it is important to consider the possible coexistence of developmental disorders in patients with intractable CVS, and to provide the reasonable accommodation and treatment for optimal outcomes. (Keyword) 周期性嘔吐症 / 自閉スペクトラム症 / risperidone / amitriptin / 個別支援 (Link to Publication Site) ● Publication site (DOI): 10.11251/ojjscn.53.54 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390005667266618880 ● Summary page in Scopus @ Elsevier: 2-s2.0-85105807980 (DOI: 10.11251/ojjscn.53.54, CiNii: 1390005667266618880, Elsevier: Scopus)
11.	Ken-ichi Suga, Issei Imoto, Hiromichi Ito, Takuya Naruto, Aya Gohji, Keita Osumi, Narumi Tokaji, Yukako Homma, Akemi Ono, Yuko Ichihara, Miki Shono, Tatsuo Mori, Maki Urushihara, Ryuji Nakagawa, Yasunobu Hayabuchi and Shoji Kagami : Next-generation sequencing for the diagnosis of patients with congenital multiple anomalies and / or intellectual disabilities, The Journal of Medical Investigation : JMI, Vol.67, No.3, 4, 246-249, 2020. (Summary) Background : In clinical practice, a large proportion of patients with multiple congenital anomalies and/or intellectual disabilities (MCA / ID) lacks a specific diagnosis. Recently, next-generation sequencing (NGS) has become an efficient strategy for genetic diagnosis of patients with MCA/ID. To review the utility of NGS for the diagnosis of patients with MCA / ID. Patients with MCA/ID were recruited between 2013 and 2017. Molecular diagnosis was performed using NGS-based targeted panel sequencing for 4,813 genes. Promising causative variants underwent confirmation by Sanger sequencing or chromosomal microarray. Eighteen patients with MCA/ID were enrolled in this study. Of them, 8 cases (44%) were diagnosed by targeted panel sequencing. Most of diagnosed patients were able to receive better counseling and more appropriate medical management. NGS-based targeted panel sequencing seems to be an effective testing strategy for diagnosis of patients with MCA/ID. J. Med. Invest. 67 : 246-249, August, 2020. (Keyword) intellectual disability / multiple congenital anomalies / next-generation sequencing / targeted panel sequencing (Tokushima University Institutional Repository) ● Metadata: 115412 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.67.246 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33148896 ● Summary page in Scopus @ Elsevier: 2-s2.0-85095598029 (Tokushima University Institutional Repository: 115412, DOI: 10.2152/jmi.67.246, PubMed: 33148896, Elsevier: Scopus)
12.	Keita Osumi, Ken-ichi Suga, Akemi Ono, Aya Gohji, Tatsuo Mori, Yukiko Kinoshita, Mikio Sugano, Yoshihiro Touda, Maki Urushihara, Ryuji Nakagawa, Yasunobu Hayabuchi, Issei Imoto and Shoji Kagami : Molecular diagnosis of an infant with TSC2/ PKD1 contiguous gene syndrome, Human Genome Variation, Vol.7, No.21, 2020. (Summary) A 1-month-old Japanese infant with cardiac rhabdomyoma was diagnosed with / contiguous gene syndrome by targeted panel sequencing with subsequent quantitative polymerase chain reaction that revealed gross monoallelic deletion, including parts of two genes: exons 19-42 of and exons 2-46 of . Early molecular diagnosis can help to detect bilateral renal cyst formation and multidisciplinary follow-up of this multisystem disease. (Tokushima University Institutional Repository) ● Metadata: 116193 (Link to Publication Site) ● Publication site (DOI): 10.1038/s41439-020-0108-0 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32695431 ● Summary page in Scopus @ Elsevier: 2-s2.0-85088011488 (Tokushima University Institutional Repository: 116193, DOI: 10.1038/s41439-020-0108-0, PubMed: 32695431, Elsevier: Scopus)
13.	Kentaro Okamoto, Takahiro Motoki, Isao Saito, Risako Urate, Kaori Aibara, Toshihiro Jogamoto, Mitsumasa Fukuda, Hiroyuki Wakamoto, Satoshi Maniwa, Yoichi Kondo, Yoshihiro Toda, Aya Goji, Tatsuo Mori, Tomohiro Soga, Yukihiko Konishi, Shigehiro Nagai, Yoko Takami, Chiho Tokorodani, Ritsuo Nishiuchi, Daisuke Usui, Rina Ando, Satoshi Tada, Yuki Yamanishi, Masahiro Nagai, Reiko Arakawa, Kayoko Saito, Hisahide Nishio, Eiichi Ishii and Mariko Eguchi : Survey of patients with spinal muscular atrophy on the island of Shikoku, Japan., Brain & Development, Vol.42, No.8, 594-602, 2020. (Summary) Our data showed the prevalence of SMA types 2 and 3 was relatively low on Shikoku compared with previous reports from other countries, suggesting delayed diagnosis may affect the results. Remaining motor function may be one predicting factor. Greater awareness of SMA among clinicians and patients seems necessary for more accurate epidemiological studies. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2020.05.004 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32505480 ● Search Scopus @ Elsevier (PMID): 32505480 ● Search Scopus @ Elsevier (DOI): 10.1016/j.braindev.2020.05.004 (DOI: 10.1016/j.braindev.2020.05.004, PubMed: 32505480)
14.	Takahiro Tayama, Tatsuo Mori, Aya Goji, Yoshihiro Toda and Shoji Kagami : Improvement of epilepsy with lacosamide in a patient with ring chromosome 20 syndrome., Brain & Development, Vol.42, No.6, 473-476, 2020. (Summary) Although VPA and LTG are generally effective for the treatment of ring chromosome 20 syndrome, they do not completely suppress seizures. LCM can be considered an effective option for seizure control in patients with this syndrome. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2020.03.003 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32247529 ● Search Scopus @ Elsevier (PMID): 32247529 ● Search Scopus @ Elsevier (DOI): 10.1016/j.braindev.2020.03.003 (DOI: 10.1016/j.braindev.2020.03.003, PubMed: 32247529)
15.	Tatsuo Mori, Hiromichi Ito, Masafumi Harada, Sonoka Hisaoka, Yuki Matsumoto, Aya Goji, Yoshihiro Toda, Kenji Mori and Shoji Kagami : Multi-delay arterial spin labeling brain magnetic resonance imaging study for pediatric autism., Brain & Development, Vol.42, No.4, 315-321, 2020. (Summary) Arterial spin labeling (ASL) is a non-invasive magnetic resonance imaging (MRI) technique that can measure regional cerebral blood flow (rCBF) without radiation exposure. This study aimed to evaluate rCBF in individuals with autism and their age-matched controls, globally and regionally. (Tokushima University Institutional Repository) ● Metadata: 114394 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2020.01.007 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32088024 ● Search Scopus @ Elsevier (PMID): 32088024 ● Search Scopus @ Elsevier (DOI): 10.1016/j.braindev.2020.01.007 (Tokushima University Institutional Repository: 114394, DOI: 10.1016/j.braindev.2020.01.007, PubMed: 32088024)
16.	Tatsuo Mori, Yoshihiro Touda, Hiromichi Ito, Kenji Mori, Tomohiro Kohmoto, Issei Imoto and Shoji Kagami : A 16q22.2-q23.1 deletion identified in a male infant with West syndrome., Brain & Development, 2019. (Summary) In partial monosomy of the distal part of chromosome 16q, abnormal facial features, intellectual disability (ID), and feeding dysfunction are often reported. However, seizures are not typical and the majority of them were seizure-free. Here we present the case of a 16q22.2-q23.1 interstitial deletion identified in a male patient with severe ID, facial anomalies including forehead protrusions and flat nose bridge, patent ductus arteriosus, bilateral vocal cord atresia treated by tracheotomy, and West syndrome, which were developed 10months after birth. Although phenobarbital, sodium valproate (VPA), and zonisamide were not effective as monotherapies or combination therapies, the patient's epileptic seizures and electroencephalogram anomalies disappeared following combined therapy with lamotrigine and VPA. Although WW Domain Containing Oxidoreductase (WWOX), which is known as a cause of autosomal recessive epileptic encephalopathy, was included within the 6.8-Mb deleted region which identified by targeted panel sequencing and validated by chromosomal microarray analysis, no pathogenic variants were detected in the other allele of WWOX. Therefore, it is possible that other genes within or outside of the long deleted region or their interactions may cause West syndrome in this patient. (Tokushima University Institutional Repository) ● Metadata: 114240 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2019.07.005 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31353122 ● Search Scopus @ Elsevier (PMID): 31353122 ● Search Scopus @ Elsevier (DOI): 10.1016/j.braindev.2019.07.005 (Tokushima University Institutional Repository: 114240, DOI: 10.1016/j.braindev.2019.07.005, PubMed: 31353122)
17.	Kenji Mori, 田山貴広, Aya Gohji, Tatsuo Mori and Yoshihiro Touda : けいれんと間違えやすい生理的運動・異常行動., 小児内科, No.50, 541-544, 2018.
18.	Hiromichi Ito, Kenji Mori, Masafumi Harada, Sonoka Hisaoka, Yoshihiro Touda, Tatsuo Mori, Aya Gohji, Yoko Abe, Masahito Miyazaki and Shoji Kagami : A Proton Magnetic Resonance Spectroscopic Study in Autism Spectrum Disorder Using a 3-Tesla Clinical Magnetic Resonance Imaging (MRI) System: The Anterior Cingulate Cortex and the Left Cerebellum., Journal of Child Neurology, Vol.32, No.8, 731-739, 2017. (Summary) The pathophysiology of autism spectrum disorder (ASD) is not fully understood. We used proton magnetic resonance spectroscopy to investigate metabolite concentration ratios in the anterior cingulate cortex and left cerebellum in ASD. In the ACC and left cerebellum studies, the ASD group and intelligence quotient- and age-matched control group consisted of 112 and 114 subjects and 65 and 45 subjects, respectively. In the ASD group, γ-aminobutyric acid (GABA)+/ creatine/phosphocreatine (Cr) was significantly decreased in the anterior cingulate cortex, and glutamate (Glu)/Cr was significantly increased and GABA+/Cr was significantly decreased in the left cerebellum compared to those in the control group. In addition, both groups showed negative correlations between Glu/Cr and GABA+/Cr in the left cerebellum, and positive correlations between GABA+/Cr in the anterior cingulate cortex and left cerebellum. ASD subjects have hypoGABAergic alterations in the anterior cingulate cortex and hyperglutamatergic/hypoGABAergic alterations in the left cerebellum. (Keyword) Adolescent / Aspartic Acid / Autism Spectrum Disorder / cerebellum / Child / Child, Preschool / Choline / Creatine / Female / Gyrus Cinguli / Humans / Imaging, Three-Dimensional / magnetic resonance imaging / Male / Proton Magnetic Resonance Spectroscopy / gamma-Aminobutyric Acid (Link to Publication Site) ● Publication site (DOI): 10.1177/0883073817702981 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28420309 ● Summary page in Scopus @ Elsevier: 2-s2.0-85021191879 (DOI: 10.1177/0883073817702981, PubMed: 28420309, Elsevier: Scopus)
19.	Aya Goji, Hiromichi Ito, Kenji Mori, Masafumi Harada, Sonoka Hisaoka, Yoshihiro Touda, Tatsuo Mori, Yoko Abe, Masahito Miyazaki and Shoji Kagami : Assessment of Anterior Cingulate Cortex (ACC) and Left Cerebellar Metabolism in Asperger's Syndrome with Proton Magnetic Resonance Spectroscopy (MRS)., PLoS ONE, No.1, e0169288, 2017. (Summary) Proton magnetic resonance spectroscopy (1H MRS) is a noninvasive neuroimaging method to quantify biochemical metabolites in vivo and it can serve as a powerful tool to monitor neurobiochemical profiles in the brain. Asperger's syndrome (AS) is a type of autism spectrum disorder, which is characterized by impaired social skills and restrictive, repetitive patterns of interest and activities, while intellectual levels and language skills are relatively preserved. Despite clinical aspects have been well-characterized, neurometabolic profiling in the brain of AS remains to be clear. The present study used proton magnetic resonance spectroscopy (1H MRS) to investigate whether pediatric AS is associated with measurable neurometabolic abnormalities that can contribute new information on the neurobiological underpinnings of the disorder. Study participants consisted of 34 children with AS (2-12 years old; mean age 5.2 (±2.0); 28 boys) and 19 typically developed children (2-11 years old; mean age 5.6 (±2.6); 12 boys) who served as the normal control group. The 1H MRS data were obtained from two regions of interest: the anterior cingulate cortex (ACC) and left cerebellum. In the ACC, levels of N-acetylaspartate (NAA), total creatine (tCr), total choline-containing compounds (tCho) and myo-Inositol (mI) were significantly decreased in children with AS compared to controls. On the other hand, no significant group differences in any of the metabolites were found in the left cerebellum. Neither age nor sex accounted for the metabolic findings in the regions. The finding of decreased levels of NAA, tCr, tCho, and mI in the ACC but not in left cerebellar voxels in the AS, suggests a lower ACC neuronal density in the present AS cohort compared to controls. (Keyword) Aspartic Acid / Asperger Syndrome / cerebellum / children / Child, Preschool / Choline / Creatine / Female / Gyrus Cinguli / Humans / Inositol / Male / Proton Magnetic Resonance Spectroscopy (Tokushima University Institutional Repository) ● Metadata: 112363 (Link to Publication Site) ● Publication site (DOI): 10.1371/journal.pone.0169288 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28060873 ● Summary page in Scopus @ Elsevier: 2-s2.0-85009237719 (Tokushima University Institutional Repository: 112363, DOI: 10.1371/journal.pone.0169288, PubMed: 28060873, Elsevier: Scopus)
20.	Tomokazu Kimizu, Yukitoshi Takahashi, Taikan Oboshi, Asako Horino, Takayoshi Koike, Shinsaku Yoshitomi, Tatsuo Mori, Tokito Yamaguchi, Hiroko Ikeda, Nobuhiko Okamoto, Mitsuko Nakashima, Hirotomo Saitsu, Mitsuhiro Kato, Naomichi Matsumoto and Katsumi Imai : A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy., Brain & Development, Vol.39, No.3, 256-260, 2016. (Summary) This report reviewed the clinical features of patients with a SLC35A2 mutation. ACTH therapy may be effective for refractory epilepsy in these patients. (Keyword) Age of Onset / Brain Diseases / Congenital Disorders of Glycosylation / Electroencephalography / Epilepsy / Female / Humans / Infant / Magnetic Resonance Imaging / Monosaccharide Transport Proteins / Mutation / Spasms, Infantile (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2016.09.009 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27743886 ● Search Scopus @ Elsevier (PMID): 27743886 ● Search Scopus @ Elsevier (DOI): 10.1016/j.braindev.2016.09.009 (DOI: 10.1016/j.braindev.2016.09.009, PubMed: 27743886)
21.	Tatsuo Mori, Yukitoshi Takahashi, Nami Araya, Taikan Oboshi, Hirokazu Watanabe, Kazuki Tsukamoto, Tokito Yamaguchi, Shinsaku Yoshitomi, Hirosato Nasu, Hiroko Ikeda, Hideyuki Otani, Katsumi Imai, Hideo Shigematsu and Yushi Inoue : Antibodies against peptides of NMDA-type GluR in cerebrospinal fluid of patients with epileptic spasms., European Journal of Paediatric Neurology, Vol.20, No.6, 865-873, 2016. (Summary) The CSF level of antibodies against GluN2B in ES patients with unknown cause was estimated to increase after onset. We hypothesize that some ES patients may have immune process after the onset of ES. (Keyword) Autoantibodies / Child / Child, Preschool / Female / Humans / Infant / Male / Protein Subunits / Receptors, N-Methyl-D-Aspartate / Spasms, Infantile (Link to Publication Site) ● Publication site (DOI): 10.1016/j.ejpn.2016.07.006 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27515477 ● Search Scopus @ Elsevier (PMID): 27515477 ● Search Scopus @ Elsevier (DOI): 10.1016/j.ejpn.2016.07.006 (DOI: 10.1016/j.ejpn.2016.07.006, PubMed: 27515477)
22.	Tatsuo Mori, Katsumi Imai, Taikan Oboshi, Yuh Fujiwara, Saoko Takeshita, Hirotomo Saitsu, Naomichi Matsumoto, Yukitoshi Takahashi and Yushi Inoue : Usefulness of ketogenic diet in a girl with migrating partial seizures in infancy., Brain & Development, Vol.38, No.6, 601-604, 2016. (Summary) Migrating partial seizures in infancy (MPSI) are an age-specific epilepsy syndrome characterized by migrating focal seizures, which are intractable to various antiepileptic drugs and cause severe developmental delay. We report a case of MPSI with heterozygous missense mutation in KCNT1, which was successfully managed by ketogenic diet. At age 2months, the patient developed epilepsy initially manifesting focal seizures with eye deviation and apnea, then evolving to secondarily generalized clonic convulsion. Various antiepileptic drugs including phenytoin, valproic acid, zonisamide, clobazam, levetiracetam, vitamin B6, and carbamazepine were not effective, but high-dose phenobarbital allowed discontinuation of midazolam infusion. Ictal scalp electroencephalogram showed migrating focal seizures. MPSI was suspected and she was transferred to our hospital for further treatment. Potassium bromide (KBr) was partially effective, but the effect was transient. High-dose KBr caused severe adverse effects such as over-sedation and hypercapnia, with no further effects on the seizures. At age 9months, we started a ketogenic diet, which improved seizure frequency and severity without obvious adverse effects, allowing her to be discharged from hospital. Ketogenic diet should be tried in patients with MPSI unresponsive to antiepileptic drugs. In MPSI, the difference in treatment response in patients with and those without KCNT1 mutation remains unknown. Accumulation of case reports would contribute to establish effective treatment options for MPSI. (Keyword) Anticonvulsants / Brain / Combined Modality Therapy / Electroencephalography / Epilepsies, Partial / Female / Follow-Up Studies / Humans / Infant / Ketogenic Diet / Nerve Tissue Proteins / Potassium Channels / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2015.12.012 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26785903 ● Search Scopus @ Elsevier (PMID): 26785903 ● Search Scopus @ Elsevier (DOI): 10.1016/j.braindev.2015.12.012 (DOI: 10.1016/j.braindev.2015.12.012, PubMed: 26785903)
23.	Kenji Mori, Yoshihiro Touda, Hiromichi Ito, Tatsuo Mori, Keiko Mori, Aya Goji, Hiroko Hashimoto, Hiroe Tani, Masahito Miyazaki, Masafumi Harada and Shoji Kagami : Neuroimaging in autism spectrum disorders: 1H-MRS and NIRS study, The Journal of Medical Investigation : JMI, Vol.62, No.1-2, 29-36, 2015. (Summary) Using proton magnetic resonance spectroscopy ((1)H-MRS), we measured chemical metabolites in the left amygdala and the bilateral orbito-frontal cortex (OFC) in children with autism spectrum disorders (ASD). The concentrations of N-acetylaspartate (NAA) in these regions of ASD were significantly decreased compared to those in the control group. In the autistic patients, the NAA concentrations in these regions correlated with their social quotient. These findings suggest the presence of neuronal dysfunction in the amygdala and OFC in ASD. Dysfunction in the amygdala and OFC may contribute to the pathogenesis of ASD. We performed a near-infrared spectroscopy (NIRS) study to evaluate the mirror neuron system in children with ASD. The concentrations of oxygenated hemoglobin (oxy-Hb) were measured with frontal probes using a 34-channel NIRS machine while the subjects imitated emotional facial expressions. The increments in the concentration of oxy-Hb in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls. However, the concentrations of oxy-Hb in this area were significantly elevated in autistic subjects after they were trained to imitate emotional facial expressions. The results suggest that mirror neurons could be activated by repeated imitation in children with ASD. (Tokushima University Institutional Repository) ● Metadata: 111242 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.62.29 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25817280 ● Summary page in Scopus @ Elsevier: 2-s2.0-84925849527 (Tokushima University Institutional Repository: 111242, DOI: 10.2152/jmi.62.29, PubMed: 25817280, Elsevier: Scopus)
24.	Tatsuo Mori, Kenji Mori, Hiromichi Ito, Aya Goji, Masahito Miyazaki, Masafumi Harada, Kenji Kurosawa and Shoji Kagami : Age-related changes in a patient with Pelizaeus-Merzbacher disease determined by repeated 1H-magnetic resonance spectroscopy., Journal of Child Neurology, Vol.29, No.2, 283-288, 2014. (Summary) A boy with Pelizaeus-Merzbacher disease underwent repeated evaluations by 3-Tesla (1)H-magnetic resonance spectroscopy (MRS). The patient showed overlap of the PLP1. Individuals selected as normal controls for (1)H-magnetic resonance spectroscopy consisted of healthy age-matched children. For (1)H-magnetic resonance spectroscopy, the center of a voxel was positioned in the right parietal lobe. (1)H-magnetic resonance spectroscopy was performed when the patient was 2, 6, 14, and 25 months old. γ-Aminobutyric acid concentration in early childhood was increased compared with that in normal controls. However, the γ-aminobutyric acid concentration in the Pelizaeus-Merzbacher disease patient was normalized at 14 and 25 months. No remarkable changes were observed in choline-containing compounds concentration at any time. These results suggest that the changes in metabolite concentrations during growth can reflect the pathological condition of Pelizaeus-Merzbacher disease. Furthermore, the lack of change in the choline-containing compounds concentration can be useful for differentiating Pelizaeus-Merzbacher disease from other white matter disorders. (Keyword) aging / Aspartic Acid / Case-Control Studies / Child, Preschool / Creatine / Glutamic Acid / Humans / infant / Inositol / Magnetic Resonance Spectroscopy / Male / Parietal Lobe / Pelizaeus-Merzbacher Disease / gamma-Aminobutyric Acid (Tokushima University Institutional Repository) ● Metadata: 114870 (Link to Publication Site) ● Publication site (DOI): 10.1177/0883073813499635 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24056155 ● Summary page in Scopus @ Elsevier: 2-s2.0-84892723051 (Tokushima University Institutional Repository: 114870, DOI: 10.1177/0883073813499635, PubMed: 24056155, Elsevier: Scopus)
25.	Kenji Mori, Tatsuo Mori, 郷司彩, Hiromichi Ito, Yoshihiro Touda, Emiko Fujii, 宮崎雅仁, Masafumi Harada and Shoji Kagami : Hemodynamic activities in children with autism while imitating emotional facial expressions: a near-infrared spectroscopy study, No to Hattatsu, Vol.46, No.4, 281-286, 2014. (Summary) <i><b>Objective:</b></i> To examine the hemodynamic activities in the frontal lobe, children with autistic disorder and matched controls underwent near-infrared spectroscopy (NIRS) while imitating emotional facial expressions. <i><b>Methods:</b></i> The subjects consisted of 10 boys with autistic disorder without mental retardation (9∼14 years) and 10 normally developing boys (9∼14 years). The concentrations of oxyhemoglobin (oxy-Hb) were measured with frontal probes using a 34-channel NIRS machine while the subjects imitated emotional facial expressions. <i><b>Results:</b></i> The increments in the concentration of oxy-Hb in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls. However, the concentrations of oxy-Hb in this area were significantly elevated in autistic subjects after they were trained to imitate emotional facial expressions. The increments in the concentration of oxy-Hb in this area in autistic subjects were positively correlated with the scores on a test of labeling emotional facial expressions. <i><b>Conclusions:</b></i> The pars opercularis of the inferior frontal gyrus is an important component of the mirror neuron system. The present results suggest that mirror neurons could be activated by repeated imitation in children with autistic disorder. (Keyword) 自閉症 / ミラーニューロン / 近赤外線スペクトロスコピー (NIRS) / 表情模倣 / Broca野 (Link to Publication Site) ● Publication site (DOI): 10.11251/ojjscn.46.281 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25154225 ● CiNii @ National Institute of Informatics (CRID): 1390001205518257920 ● Summary page in Scopus @ Elsevier: 2-s2.0-84904503404 (DOI: 10.11251/ojjscn.46.281, PubMed: 25154225, CiNii: 1390001205518257920, Elsevier: Scopus)
26.	Tatsuo Mori, Kenji Mori, Masashi Suzue, Hiromichi Ito and Shoji Kagami : Effective treatment of a 13-year-old boy with steroid-dependent ocular myasthenia gravis using tacrolimus, Brain & Development, Vol.35, No.5, 445-448, 2013. (Summary) Over the past several years, tacrolimus has attracted attention as a new therapeutic drug for myasthenia gravis (MG), but few reports have considered its use for MG in pediatric patients, and most of these have focused on severe systemic MG. In this case report, we used tacrolimus to successfully treat a 13-year-old boy with ocular MG who had suffered from severe steroid complications, including a failure of thrive and osteoporosis. He first showed symptoms of ocular MG at age 2 years 3 months. At age 13 years, he was receiving PSL (3.75 mg/day), but the symptoms of ocular MG recurred. We increased the dosage of oral PSL up to 30 mg/day, and three courses of mPSL pulse therapy were applied, but these therapies had only limited effect, and his symptoms worsened. Tacrolimus was started at 0.4 mg/day (0.011 mg/kg/day), and every 2 weeks the dose was gradually increased by 0.2 mg/day. His symptoms of MG began to improve 3 weeks after the initial administration of tacrolimus. Approximately 3 months after the start of tacrolimus administration, PSL was discontinued. Currently, at 1 year and 4 months after the start of tacrolimus administration, while slight ptosis is observed in the evening, it does not influence his daily life, and his condition remains comparable to that when he stopped taking PSL. No adverse effects of tacrolimus have been recognized. In pediatric patients with steroid-dependent ocular MG without thymectomy, tacrolimus may be a safe and effective alternative to steroid and thymectomy. (Keyword) Adolescent / Body Weight / Developmental Disabilities / Follow-Up Studies / Humans / Immunosuppressive Agents / Male / Myasthenia Gravis / Tacrolimus (Tokushima University Institutional Repository) ● Metadata: 114873 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2012.06.012 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22840813 ● Summary page in Scopus @ Elsevier: 2-s2.0-84875894491 (Tokushima University Institutional Repository: 114873, DOI: 10.1016/j.braindev.2012.06.012, PubMed: 22840813, Elsevier: Scopus)
27.	Tatsuo Mori, Kenji Mori, Emiko Fujii, Yoshihiro Touda, Masahito Miyazaki, Masafumi Harada, Toshiaki Hashimoto and Shoji Kagami : Evaluation of the GABAergic nervous system in autistic brain: (123)I-iomazenil SPECT study., Brain & Development, Vol.34, No.8, 648-654, 2012. (Summary) To evaluate the GABA(A) receptor in the autistic brain, we performed (123)I-IMZ SPECT in patients with ASD. We compared (123)I-IMZ SPECT abnormalities in patients who showed intellectual disturbance or focal epileptic discharge on EEG to those in patients without such findings. The subjects consisted of 24 patients with ASD (mean age, 7.3±3.5 years), including 9 with autistic disorder (mean age, 7.0±3.7 years) and 15 with Asperger's disorder (mean age, 7.5±3.2 years). We used 10 non-symptomatic partial epilepsy patients (mean age, 7.8±3.6 years) without intellectual delay as a control group. For an objective evaluation of the (123)I-IMZ SPECT results, we performed an SEE (Stereotactic Extraction Estimation) analysis to describe the decrease in accumulation in each brain lobule numerically. In the comparison of the ASD group and the control group, there was a dramatic decrease in the accumulation of (123)I-IMZ in the superior and medial frontal cortex. In the group with intellectual impairment and focal epileptic discharge on EEG, the decrease in accumulation in the superior and medial frontal cortex was greater than that in the group without these findings. The present results suggest that disturbance of the GABAergic nervous system may contribute to the pathophysiology and aggravation of ASD, since the accumulation of (123)I-IMZ was decreased in the superior and medial frontal cortex, which is considered to be associated with inference of the thoughts, feelings, and intentions of others (Theory of Mind). (Keyword) Adolescent / brain / children / Child Development Disorders, Pervasive / Child, Preschool / Flumazenil / Humans / Iodine Radioisotopes / Radiopharmaceuticals / Tomography, Emission-Computed, Single-Photon / gamma-Aminobutyric Acid (Tokushima University Institutional Repository) ● Metadata: 114872 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.braindev.2011.10.007 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22099869 ● Summary page in Scopus @ Elsevier: 2-s2.0-84864781015 (Tokushima University Institutional Repository: 114872, DOI: 10.1016/j.braindev.2011.10.007, PubMed: 22099869, Elsevier: Scopus)
28.	Tatsuo Mori, Kenji Mori, Emiko Fujii, Yoshihiro Touda, Masahito Miyazaki, Masafumi Harada and Shoji Kagami : Neuroradiological and neurofunctional examinations for patients with 22q11.2 deletion., Neuropediatrics, Vol.42, No.6, 215-221, 2011. (Summary) Since the neuroradiological features of patients with 22q11.2 deletion syndrome are not well-understood, examinations using functional imaging were performed in this study. Brain magnetic resonance imaging (MRI) and 1H-magnetic resonance spectroscopy (MRS) were performed using a clinical 3-Tesla MR imager in 4 patients with 22q11.2 deletion syndrome (2 boys and 2 girls; aged 2-6 years.) and 20 age- and sex-matched healthy control subjects. Furthermore, interictal 123I-iomazenil (IMZ) single photon emission computed tomography (SPECT) was examined in 2 of the 4 patients. Among the 4 patients with 22q11.2 deletion syndrome, 2 patients showed polymicrogyria and 1 patient showed agyria. Those patients with brain malformations also showed abnormal brain artery patterns and decreased accumulation of IMZ in 123I-IMZ SPECT. Although all 4 patients showed epileptic discharges in their electroencephalograms (EEG), one patient with polymicrogyria had no seizure episodes. Decreases in γ-aminobutyric acid (GABA) corresponding to the areas of polymicrogyria and/or epileptic discharges in EEG were shown in all patients except for the patient with agyria. Although consistent evidence was not seen in patients with 22q11.2 deletion syndrome in this study, brain malformations and disturbances of the GABAergic nervous system would be underlying mechanisms of the neurodevelopmental abnormalities in this syndrome. (Keyword) Case-Control Studies / children / Child, Preschool / DiGeorge Syndrome / Electroencephalography / Epilepsy / Female / Flumazenil / Humans / hydrogen / magnetic resonance imaging / nuclear magnetic resonance spectroscopy / Male / Malformations of Cortical Development / Tomography, Emission-Computed, Single-Photon / gamma-Aminobutyric Acid (Tokushima University Institutional Repository) ● Metadata: 114871 (Link to Publication Site) ● Publication site (DOI): 10.1055/s-0031-1295479 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22131192 ● Summary page in Scopus @ Elsevier: 2-s2.0-83655165118 (Tokushima University Institutional Repository: 114871, DOI: 10.1055/s-0031-1295479, PubMed: 22131192, Elsevier: Scopus)
29.	Tatsuo Mori, Takanori SEKIGUCHI, Kazumi OKAMURA, Maki SHIMIZU, Tomoko TAKAHASHI, Hiroko KOUZAN, Zenichi SAKAGUCHI and Katsuaki OHARA : A Case of Focal Cortical Dysplasia Developing into Pharmacoresistant Epilepsy on Postnatal Day 9, The Journal of the Japan Pediatric Society, Vol.114, No.9, 1436-1441, 2010. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520572359367385088 (CiNii: 1520572359367385088)
30.	Tatsuo Mori, Takanori SEKIGUCHI, Kazumi OKAMURA, Maki SHIMIZU, Tomoko TAKAHASHI, Hiroko KOUZAN, Zenichi SAKAGUCHI and Katsuaki OHARA : Cerebral Infarction Occurring Four Months after Contraction of Varicella, The Journal of the Japan Pediatric Society, Vol.114, No.3, 510-514, 2010. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520009407405635072 (CiNii: 1520009407405635072)
31.	Tatsuo Mori, 関口隆憲 and Kazumi Okamura : A case of disseminated neonatal herpes simplex virus infection, Japanese Journal of Pediatrics, Vol.62, No.10, 2233-2238, 2009. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523669554611294208 (CiNii: 1523669554611294208)

Academic Paper (Unrefereed Paper):

1.	Asuna Sugimoto, 河原林啓太, Yoshihiro Touda, Tatsuo Mori, Aya Gohji, Shoji Kagami and Tsutomu Iwamoto : 口腔筋機能療法の可能性と展望, 小児保健とくしま, Vol.27, No.1, 23-26, 2019.
2.	Narumi Tokaji, Hiromichi Ito, Tomohiro Kohmoto, Takuya Naruto, Rizu Takahashi, Aya Gohji, Tatsuo Mori, Yoshihiro Touda, Masako Saito, Shoichiro Tange, Kiyoshi Masuda, Shoji Kagami and Issei Imoto : A rare male patient with classic Rett syndrome caused by MeCP2_e1 mutation, American Journal of Medical Genetics. Part A., Vol.176A, No.3, 699-702, 2018. (Summary) Rett syndrome (RTT) is a severe neurodevelopmental disorder typically affecting females. It is mainly caused by loss-of-function mutations that affect the coding sequence of exon 3 or 4 of methyl-CpG-binding protein 2 (MECP2). Severe neonatal encephalopathy resulting in death before the age of 2 years is the most common phenotype observed in males affected by a pathogenic MECP2 variant. Mutations in MECP2 exon 1 affecting the MeCP2_e1 isoform are relatively rare causes of RTT in females, and only one case of a male patient with MECP2-related severe neonatal encephalopathy caused by a mutation in MECP2 exon 1 has been reported. This is the first reported case of a male with classic RTT caused by a 5-bp duplication in the open-reading frame of MECP2 exon 1 (NM_001110792.1:c.23_27dup) that introduced a premature stop codon [p.(Ser10Argfs*36)] in the MeCP2_e1 isoform, which has been reported in one female patient with classic RTT. Therefore, both males and females displaying at least some type of MeCP2_e1 mutation may exhibit the classic RTT phenotype. (Keyword) Alternative Splicing / Base Sequence / brain / Child, Preschool / DNA Mutational Analysis / Exons / Genetic Association Studies / Genetic Predisposition to Disease / Humans / magnetic resonance imaging / male / Methyl-CpG-Binding Protein 2 / Mutation / Phenotype / Rett Syndrome (Link to Publication Site) ● Publication site (DOI): 10.1002/ajmg.a.38595 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29341476 ● Summary page in Scopus @ Elsevier: 2-s2.0-85042076423 (DOI: 10.1002/ajmg.a.38595, PubMed: 29341476, Elsevier: Scopus)
3.	Kenji Mori, 森慶子, Kaoru Furukawa, Kumi Takahashi, Hiroko Hashimoto, Hiromichi Ito, Aya Gohji, Tatsuo Mori, Yoshihiro Touda and Shoji Kagami : 脳科学から読み解く発達障害, 小児保健とくしま, Vol.26, 10-18, 2018.
4.	Hiromichi Ito, Kenji Mori, Tatsuo Mori, A Goji and Shoji Kagami : Case of early childhood-onset narcolepsy with cataplexy: comparison with a monozygotic co-twin., Pediatrics International, Vol.56, No.5, 789-793, 2014. (Summary) We describe here a rare case of early childhood-onset (5 years of age) narcolepsy. This case was interesting because of the ability to compare the patient's symptoms to the condition of her healthy monozygotic co-twin sister. The only environmental difference between the co-twins was head injury, which may be associated with the presence of narcolepsy. The co-twin was extroverted, sociable, reliable, and dexterous. In contrast, the patient could be described as introverted, gentle, honest and persevering, but was weak at conversation, assessment of a situation, memory, planning, activity (she was inactive), a sense of time, understanding of an analog clock, operating efficiency, and physical education (due to obesity). The sisters showed the same degree of appetite and dexterity with their fingers. Narcolepsy is often under-recognized or underdiagnosed, especially when the onset occurs in childhood. When we observe preschoolers with excessive daytime sleepiness, we should consider the possibility of narcolepsy with cataplexy. (Link to Publication Site) ● Publication site (DOI): 10.1111/ped.12377 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25336002 ● Summary page in Scopus @ Elsevier: 2-s2.0-84939224466 (DOI: 10.1111/ped.12377, PubMed: 25336002, Elsevier: Scopus)

Review, Commentary:

1.	Tatsuo Mori : 特集一般小児科医のための小児てんかん診療ガイド 10.てんかん患児と家族を支えるための配慮や制度, Pediatrics of Japan, Vol.63, No.9, 1017-1026, Sep. 2022. (Link to Publication Site) ● Publication site (DOI): 10.18888/sh.0000002283 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390012014702228480 ● Search Scopus @ Elsevier (DOI): 10.18888/sh.0000002283 (DOI: 10.18888/sh.0000002283, CiNii: 1390012014702228480)
2.	Kenji Mori, 阿部容子, Tatsuo Mori, Hiromichi Ito and Yoshihiro Touda : [てんかん] ピンポイント小児医療てんかんの診断青年期以降にみられるてんかん., 小児内科, Vol.47, No.9, 1468-1470, 2015.

Proceeding of International Conference:

1.	Aya Gohji, Hiromichi Ito, N Tokaji, T Kohmoto, T Naruto, R Takahashi, Tatsuo Mori, Yoshihiro Touda, M Saito, S Tange, K Masuda, Shoji Kagami and I Imoto : A Rare Male Patient with Classic Rett Syndrome Caused by MeCP2_e1 Mutation., ASHG 2017 annual meeting, Oct. 2017.
2.	Aya Gohji, Hiromichi Ito, Kenji Mori, S Hisaoka, Yoshihiro Touda, Tatsuo Mori, Y Abe, M Miyazaki and Shoji Kagami : Metabolic dysfunction in anterior cingulate cortex using a magnetic resonance spectroscopy in Asperger's syndrome., Pediatric Academic Societies Meeting, May 2016.

Proceeding of Domestic Conference:

1.	Yoshiteru Tada, Toshitaka Fujihara, 泉千恵, 福田直也, Masahito Nakataki, Tatsuo Mori, Hiroki Yamazaki and Yasushi Takagi : 「誰も取り残さない」てんかんの医療費助成・福祉サービスの提供, 第56回日本てんかん学会学術集会, Oct. 2023.
2.	森慶子, Kenji Mori, 野崎夏江 (名), 岡本里恵 (名), Fumiko Murao, Kumi Takahashi, Hiroko Hashimoto, Takahiro Tayama, Aya Gohji and Tatsuo Mori : 個別学習支援を行った限局性学習症を有する子どもの脳機能評価, 小児保健とくしま, No.30, Sep. 2023. (Keyword) 限局性学習症 / 脳機能評価 / NIRS
3.	Kenji Mori, 森慶子, Kumi Takahashi, Hiroko Hashimoto, 野崎夏江 (名), Tatsuo Mori, Aya Gohji, Takahiro Tayama, Hiromichi Ito, Yoshihiro Touda and 宮崎雅仁 (名) : 読字障害を有する小学1年生におけるNIRSを用いた脳機能評価, 第65回日本小児神経学会学術集会, Vol.55, 353, May 2023. (Keyword) 読字障害 / 脳機能評価 / NIRS
4.	Tatsuo Mori, Yoshiteru Tada, Masahito Nakataki, Takahiro Tayama, Aya Gohji, Yoshihiro Touda, Toshitaka Fujihara, Hiroki Yamazaki and Kenji Mori : 徳島大学病院てんかんセンターにおけるトランジションの現状と今後の課題, 第10回全国てんかんセンター協議会総会栃木大会 2023, Mar. 2023.
5.	Yoshiteru Tada, Masahito Nakataki, Tatsuo Mori, Toshitaka Fujihara, Aya Gohji, Hiroki Yamazaki, 泉千恵, 高尾里沙, 多田雅美, 阿部修司, Kenji Mori and Yasushi Takagi : 地方におけるてんかん支援拠点病院の役割, 第10回全国てんかんセンター協議会, Feb. 2023.
6.	Aya Gohji, Hiroyuki Morino, Asami Okada, Tatsuo Mori, Ken-ichi Suga, Yumiko Kotani, 瀬山理惠, 内山由理 and 松本直通 : Coffin-siris syndrome with persistent open anterior fontanelle in a boy arising from a novel de novo ARID2 variant, 日本人類遺伝学会第67回大会, Dec. 2022.
7.	Yuki Sakaki, Tatsuo Mori, Takahiro Tayama, Aya Gohji, Yoshihiro Touda and Maki Urushihara : 乳児期の異常眼球運動発作の存在が診断の契機になったGLUT1欠損症の男児例, 中国四国小児科学会プログラム・抄録集, Vol.74, 50, Oct. 2022.
8.	Tatsuo Mori, Takahiro Tayama, Aya Gohji, Yoshihiro Touda, 坂本正宗, 松本直通 and Maki Urushihara : A girl case with myoclonic atonic epilepsy caused by SLC6A1 gene rupture due to a balanced chromosomal translocation, てんかん研究, Vol.40, No.2, 407, Sep. 2022.
9.	Takahiro Tayama, Tatsuo Mori, 郷司彩, 東田好広, Kenji Mori and Maki Urushihara : 当科におけるWest症候群に対するvigabatrinの使用経験, No to Hattatsu, Vol.54, No.6, 455, Jul. 2022.
10.	田中真波, Takahiro Tayama, 郷司彩, Tatsuo Mori and Maki Urushihara : GLUT1欠損症の1例, The Journal of the Japan Pediatric Society, Vol.127, No.6, 917, Jun. 2022.
11.	Mai Azumi, Kohhei Nakajima, 大野卓也, Aya Gohji, Tatsuo Mori, Kenji Mori and Yasushi Takagi : けいれん重積型急性脳症に類似した症状を呈し，West症候群に移行した乳児頭部外傷の1例, 第50回日本小児神経外科学会, Jun. 2022.
12.	Kenji Mori, 森慶子, Kumi Takahashi, Hiroko Hashimoto, 野﨑夏江, 河井ちひろ, Tatsuo Mori, Aya Gohji, 伊藤弘道, Yoshihiro Touda and 宮崎雅仁 : Evaluation of brain function in dyslexic children : a near-infrared spectroscopy study, 第64回日本小児神経学会学術集会, Jun. 2022. (Keyword) 読字障害 / NIRS / 脳機能評価
13.	Takahiro Tayama, 竹内竣亮, 武井美貴子, Keisuke Fujioka, Akemi Ono, Miki Shono, 七條光市, Shuji Kondo, 福良翔子, Aya Gohji, Tatsuo Mori and 高橋利幸 : 髄膜炎で発症後に，脳脊髄炎を呈した抗MOG抗体関連疾患の1例, No to Hattatsu, Vol.54, No.Suppl, S352, May 2022.
14.	Yukako Honma, Aya Gohji, Tatsuo Mori, Yasunobu Hayabuchi, Mikio Sugano, Takashi Kitaichi and Hiroki Hata : 憤怒痙攣が診断の契機となった完全大血管転位症術後における冠状動脈狭窄・心筋虚血の1乳児例, 第36回日本小児循環器学会近畿・中四国地方会, Mar. 2022.
15.	高尾里沙, 多田雅美, 安部修司, Masahito Nakataki, Tatsuo Mori, Toshitaka Fujihara, Yoshiteru Tada, Hiroki Yamazaki and Kenji Mori : てんかん相談における徳島県の現状の把握と今後の課題., 第9回全国てんかんセンター協議会総会鹿児島大会, Mar. 2022.
16.	Yoshiteru Tada, Masahito Nakataki, Tatsuo Mori, Toshitaka Fujihara, Aya Gohji, Hiroki Yamazaki, 高尾里沙, 泉千恵, 多田雅美, 安部修司 and Kenji Mori : 今後の徳島県におけるてんかん地域診療連携整備事業の展望について, 第9回全国てんかんセンター協議会総会, Mar. 2022.
17.	Tomoshi Koyama, Aya Gohji, Tatsuo Mori, Ryuji Nakagawa, Keiichiro Watanabe, Kouhei Kamoi and Junya Fukuda : Pre-epiglottic baton plateを用いて上気道狭窄に対応したPierre-Robin Sequenceの1例, 第73回中国四国小児科学会, Nov. 2021.
18.	佐藤宏紀, Tatsuo Mori, Aya Gohji, Yoshihiro Touda and Masashi Ohta : 興奮, 暴行を伴う発作後精神病の管理に難渋したLennox-Gastaut症候群の男児例., 第1回四国小児てんかんEducation Seminar., Oct. 2021.
19.	田中真波, 福良翔子, Aya Gohji, Tatsuo Mori and Yoshihiro Touda : BCG接種から約1か月でACTH療法を導入したWest症候群の1例., 第32回日本小児神経学会中国・四国地方会., Jul. 2021.
20.	Hiroki Sato, Yukako Honma, Mikio Sugano, Takashi Kitaichi, Aya Gohji, Tatsuo Mori and Yasunobu Hayabuchi : 憤怒痙攣が診断の契機となった完全大血管転位術後における冠状動脈狭窄・心筋虚血の1乳児例, 第135回日本小児科学会徳島地方会, Jun. 2021.
21.	Kenji Mori, 森慶子, Kumi Takahashi, Hiroko Hashimoto, 野﨑夏江, 河井ちひろ, Tatsuo Mori, Aya Gohji, Hiromichi Ito, Yoshihiro Touda and 宮崎雅仁 : 読字活動時における脳反応について―NIRSによる解析―．, 第63回日本小児神経学会学術集会, May 2021.
22.	竹内竣亮, Tatsuo Mori, Aya Gohji, 高橋利幸 and Yoshihiro Touda : 視覚症状のみが遷延したが，血漿交換後に症状改善を得た抗myelin oligodendrocyte glycoprotein(MOG)抗体関連疾患の男児例, No to Hattatsu, Vol.53, No.Suppl, S350, May 2021.
23.	Kenji Mori, 森慶子, 高橋久美, Saori Kamishirakawa, 河合ちひろ, Hiroko Hashimoto, Tatsuo Mori, Aya Gohji, Hiromichi Ito, Yoshihiro Touda and 宮崎雅仁 : 絵本の読み聞かせ聴取時における脳反応について-NIRS および心拍変動を用いた解析-, 第62回日本小児神経学会学術集会, Aug. 2020.
24.	Tatsuo Mori, Aya Gohji, Yoshihiro Touda, Hiromichi Ito, Toshitaka Kawarai, 藤田京志, 松本直通 and Kenji Mori : 薬剤抵抗性てんかんを合併したARID1B 遺伝子欠失を伴うCoffin-Siris症候群の女児例., 第31回日本小児神経学会中国・四国地方会, Jul. 2020.
25.	Masahito Nakataki, Hiroaki Edo, Yoshiteru Tada, Yoshihiro Touda, Toshitaka Fujihara, Tatsuo Mori, Aya Gohji, Kenji Mori and Tetsuro Ohmori : てんかん発作や精神症状と関連しない生活の質, 第53回日本てんかん学会学術集会, Nov. 2019.
26.	Yoshiteru Tada, Yoshihiro Touda, Masahito Nakataki, Toshitaka Fujihara, Tatsuo Mori, Aya Gohji, 飯田幸治, Kenji Mori and Yasushi Takagi : 徳島県におけるてんかん地域診療連携整備事業の紹介, 第53回日本てんかん学会学術集会, Oct. 2019.
27.	宮本容子, Toshitaka Kawarai, Tatsuo Mori, Aya Gohji and Masami Morimoto : Genetic counseling for children with congenital disease diagnosed with PTEN Hamartoma Tumor Syndrome by IRUD, 第43回日本遺伝カウンセリング学会, Aug. 2019.
28.	Tatsuo Mori : IRUDで解析対象となった疾患例 2) 小児科領域, 2019年度徳島大学 IRUD 講演会, Jun. 2019.
29.	Tatsuo Mori, Hiromichi Ito, Aya Gohji, Yoshihiro Touda, Kenji Mori, Masafumi Harada and Shoji Kagami : 自閉症スペクトラム症におけるArterial Spin Labeling法を用いた脳血流評価, 第61回日本小児神経学会学術集会, May 2019.
30.	Kenji Mori, Aya Gohji, Tatsuo Mori, Yoshihiro Touda, Hiromichi Ito, 宮崎雅仁 and Shoji Kagami : NIRSを用いた読字課題時の前頭葉機能評価, 第61回日本小児神経学会学術集会, May 2019.
31.	Tatsuo Mori, 田山貴広, Aya Gohji, Yoshihiro Touda and Shoji Kagami : 均衡型相互転座(46XX t(3;11)(p25;q13.1))を伴ったミオクロニー脱力発作を伴うてんかんの一女児例, 第52回日本てんかん学会学術集会, Oct. 2018.
32.	Yoshihiro Touda, Aya Gohji, Tatsuo Mori and Shoji Kagami : 小児難治性てんかんに対する新規抗てんかん薬の使用経験, 第52回日本てんかん学会学術集会, Oct. 2018.
33.	Kenji Mori, Aya Gohji, Tatsuo Mori, Yoshihiro Touda, Hiromichi Ito, 宮崎雅仁 and Shoji Kagami : 多チャンネルNIRSを用いた表情処理過程の解析, 第60回日本小児神経学会学術集会, May 2018.
34.	Hiromichi Ito, Kenji Mori, Masafumi Harada, 久岡園花, Yoshihiro Touda, Tatsuo Mori, Aya Gohji, 高見容子, 宮崎雅仁 and Shoji Kagami : 自閉スペクトラム症の頭部1H-MRSによる検討―前部帯状回と左小脳について―, 第60回日本小児神経学会学術集会, May 2018.
35.	Yoshiteru Tada, Toshitaka Fujihara, Aya Gohji, Tatsuo Mori, Yoshihiro Touda, Kenji Mori, 飯田幸治, Junichiro Satomi and Yasushi Takagi : 術前精査中にバルブロ酸の追加が著効したrolandic crtical dysplasiaに1例, 第41回日本てんかん外科学会, Jan. 2018.
36.	Yoshihiro Touda, Aya Gohji, Tatsuo Mori, Yukiko Kinoshita, Yasunobu Hayabuchi, Shoji Kagami and Issei Imoto : バルプロ酸の投与によりてんかん発症を抑制できた結節性硬化症の一例, 第51回日本てんかん学会学術集会, Nov. 2017.
37.	Kaoru Furukawa, Kenji Mori, Hiroko Hashimoto, Kumi Takahashi, Saori Kamishirakawa, Aya Gohji, Tatsuo Mori, Yoshihiro Touda, 宮崎雅仁 and Shoji Kagami : 自閉症スペクトラムにおけるNIRSを用いた表情処理過程の評価, 第118回日本小児精神神経学会, 10, Nov. 2017. (Keyword) 自閉症スペクトラム / NIRS / 表情処理 / 脳機能評価
38.	Hiromichi Ito, Kenji Mori, Yoshihiro Touda, Tatsuo Mori, Aya Gohji, 阿部容子, 宮崎雅仁 and Shoji Kagami : 注意欠如・多動症におけるてんかん・脳波異常の検討, 第59回日本小児神経学会学術集会, Jun. 2017.
39.	Kenji Mori, Aya Gohji, Tatsuo Mori, Hiromichi Ito, Yoshihiro Touda and 宮崎雅仁 : NIRSによる読字能力評価 - 無意味単語速読・単語逆唱課題による検討 -, 第59回日本小児神経学会学術集会, Jun. 2017.
40.	Yoshiteru Tada, 藤原敏孝, Kohhei Nakajima, Yoshihiro Touda, Hiromichi Ito, Tatsuo Mori, 郷司彩, 飯田幸治, 森謙治 and Shinji Nagahiro : 徳島大学てんかんセンターの取り組みと課題, 全国てんかんセンター協議会総会 JEPICA 2017 in Nara, Feb. 2017.
41.	Aya Gohji, Yoshihiro Touda, 武井美貴子, Tatsuo Mori, Hiromichi Ito and Shoji Kagami : 発作時99mTc-ECD SPECTが診断に有用であった限局性皮質異形成の乳児例, 第147回日本小児科学会徳島地方会, Dec. 2016.
42.	Yoshihiro Touda, Tatsuo Mori, Hiromichi Ito, 小林勝弘 and Shoji Kagami : CSWSに対しスルチアムが著効した症例における棘徐波に伴う高周波成分の変化, 第50回日本てんかん学会学術集会, Oct. 2016.
43.	Tatsuo Mori : Clinical conference 眼球偏位を伴う意識低下，脱力転倒を繰り返す生後8か月の男児, 第 34 回四国小児神経症例検討会, Sep. 2016.
44.	鈴木智子, Aya Gohji, Tatsuo Mori, Hiromichi Ito, Yoshihiro Touda, Kenji Mori and Shoji Kagami : フェノバルビタール大量投与が奏功した皮質形成異常を認める難治性てんかんの一例, 第34回四国小児神経症例検討会, Sep. 2016.
45.	大隅敬太, Hiromichi Ito, Yoshihiro Touda, Tatsuo Mori, Aya Gohji, Shoji Kagami, 佐々木亜由美 and Kazuhiro Mori : 急性弛緩性麻痺様症状を呈した選択性IgA欠損症の幼児例, 第146回日本小児科学会徳島地方会, Jun. 2016.
46.	阿部容子, Aya Gohji, Tatsuo Mori, Hiromichi Ito, Yoshihiro Touda and Shoji Kagami : 補足運動野発作が疑われるも，発作間欠期に側頭部棘波を示す1例, 第146回日本小児科学会徳島地方会, Jun. 2016.
47.	Aya Gohji, Hiromichi Ito, Kenji Mori, Masafumi Harada, 久岡園花, Yoshihiro Touda, Tatsuo Mori, 阿部容子, 宮崎雅仁 and Shoji Kagami : Metabolic alteration in the brain of Asperger`s syndrome by using a magnetic resonance spectroscopy, 第58回日本小児神経学会学術集会, Jun. 2016.
48.	小野朱美, Hiromichi Ito, 阿部容子, Tatsuo Mori, Yoshihiro Touda, Yasunobu Hayabuchi, Takuya Naruto, Issei Imoto and Shoji Kagami : 重症蒼白型の憤怒痙攣に対してレベチラセタムが奏効した1p36欠失症候群の1女児例, 第58回日本小児神経学会学術集会, Jun. 2016.
49.	Kenji Mori, Hiromichi Ito, Yoshihiro Touda, Tatsuo Mori, 阿部容子, 宮崎雅仁, Masafumi Harada and Shoji Kagami : 言語活動時の前頭葉血流動態 -NIRSによる黙読・音読時の比較-, 第58回日本小児神経学会学術集会, Jun. 2016.
50.	Hiromichi Ito, Kenji Mori, Yoshihiro Touda, Tatsuo Mori, Aya Gohji, 阿部容子, 宮崎雅仁 and Shoji Kagami : 自閉症スペクトラム障害におけるてんかん・脳波異常の検討, 第58回日本小児神経学会学術集会, Jun. 2016.
51.	Hiromichi Ito, Kenji Mori, Masafumi Harada, 久岡園花, Yoshihiro Touda, Tatsuo Mori, Aya Gohji, 阿部容子, 宮崎雅仁 and Shoji Kagami : 自閉症スペクトラム障害における頭部MRI所見の目視的検討, 第58回日本小児神経学会学術集会, Jun. 2016.
52.	阿部容子, 松本苑美, Tatsuo Mori, Hiromichi Ito, Yoshihiro Touda, Shoji Kagami and 高橋幸利 : 非ヘルペス性急性辺縁系脳炎の1男児例, 第119回日本小児科学会総会, May 2016.
53.	Tatsuo Mori : 先天性脈絡膜乳頭腫摘出術後に生じたencephalopathy related to status epilepticus during slow sleep(ESES)の一例, 第3回徳島小児神経科医の会, Apr. 2016.
54.	阿部容子, Tatsuo Mori, Hiromichi Ito, Yoshihiro Touda and Shoji Kagami : 非ヘルペス性急性辺縁系脳炎の一男児例, 第33回四国小児神経症例検討会, Sep. 2015.
55.	阿部容子, Tatsuo Mori, Hiromichi Ito, Yoshihiro Touda, Shoji Kagami, 松本苑美 and 吉本勉 : 非ヘルペス性急性辺縁系脳炎の一男児例, 第144回日本小児科学会徳島地方会, Jun. 2015.
56.	Hiromichi Ito, Kenji Mori, Masafumi Harada, Yoshihiro Touda, Tatsuo Mori, 郷司彩, 宮崎雅仁 and Shoji Kagami : 注意欠如・多動性障害(AD/HD)における頭部1H-MRS所見左小脳半球について, 第57回日本小児神経学会, May 2015.
57.	Hiromichi Ito, Maki Urushihara, Yukiko Kinoshita, Shuji Kondo, Kenji Mori, Tatsuo Mori, Ken-ichi Suga, Kazuhiro Mori and Shoji Kagami : 横紋筋融解症をきたしたノロウイルス性急性脳症の1例, The Journal of the Japan Pediatric Society, Vol.117, No.3, 655, 2013.

Et cetera, Workshop:

1.	Tatsuo Mori, Aya Gohji, Yoshihiro Touda, 武井美貴子, Hiromichi Ito, Shoji Kagami and 瓦井俊孝 : GCH1変異を認めた瀬川病の8歳男児例, 第151会日本小児科学会徳島地方会, Dec. 2018.
2.	Yoshihiro Touda, 田山貴広, Aya Gohji, Tatsuo Mori and Shoji Kagami : 抗てんかん剤の中止により発作が抑制されたWest症候群の男児例, 第36回四国小児神経症例検討会, Sep. 2018.
3.	Tatsuo Mori, Aya Gohji, Yoshihiro Touda, 武井美貴子, Hiromichi Ito, Toshitaka Kawarai and Shoji Kagami : GCH1遺伝子に変異を認めた瀬川病の8歳男児例, 第29回日本小児神経学会中国四国地方会, Jul. 2018.
4.	田山貴広, Tatsuo Mori, Aya Gohji, Yoshihiro Touda and Shoji Kagami : ラコサミドが著効した環状20番染色体の7歳男児例, 第150回日本小児科学会徳島地方会, Jun. 2018.
5.	田山貴広, Yoshihiro Touda, Aya Gohji, Tatsuo Mori and Shoji Kagami : ヒプスアリスミアを伴わない乳児スパズムの一例, 第48回中国四国点頭てんかん研究会, Mar. 2018.
6.	田山貴広, Tatsuo Mori, Aya Gohji, Yoshihiro Touda and Shoji Kagami : ラコサミドが著効した環状20番染色体の7歳男児例, 第 12 回日本てんかん学会中国・四国地方会, Feb. 2018.
7.	田山貴広, Yoshihiro Touda, Aya Gohji, Tatsuo Mori and Shoji Kagami : ヒプスアリスミアを伴わない乳児スパズムの1 例, 第149回日本小児科学会徳島地方会, Dec. 2017.
8.	Aya Gohji, Hiromichi Ito, 戸梶成美, Tatsuo Mori, Yoshihiro Touda, Takuya Naruto, Issei Imoto and Shoji Kagami : MeCP2-e1遺伝子変異を持つRett症候群の男児例, 第28回日本小児神経学会中国・四国地方会, Jul. 2017.
9.	四宮由貴, Aya Gohji, Tatsuo Mori, Yoshihiro Touda and Shoji Kagami : 覚醒時にチアノーゼを伴う複雑部分発作を呈した前頭葉てんかんの一例, 第148回日本小児科学会徳島地方会, Jun. 2017.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Search by Researcher Number (40599081)

Associate Professor : Mori, Tatsuo

Research

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Review, Commentary:

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)